BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24573123)

  • 21. Cancer of the external auditory canal and temporal bone.
    Kuhel WI; Hume CR; Selesnick SH
    Otolaryngol Clin North Am; 1996 Oct; 29(5):827-52. PubMed ID: 8893219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors affect the survival outcome of hard palatal and maxillary alveolus squamous cell carcinoma: 10-year review in a tertiary referral center.
    Wang TC; Hua CH; Lin CC; Tsou YA; Tseng HC; Tsai MH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul; 110(1):11-7. PubMed ID: 20299251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
    González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of bone or cartilage invasion of locally advanced head and neck cancers.
    Do L; Syed N; Puthawala A; Azawi S; Williams R; Vora N
    Am J Clin Oncol; 2010 Dec; 33(6):591-4. PubMed ID: 20065851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical look at persistent problems in the diagnosis, staging and treatment of temporal bone carcinoma.
    Zanoletti E; Lovato A; Stritoni P; Martini A; Mazzoni A; Marioni G
    Cancer Treat Rev; 2015 Dec; 41(10):821-6. PubMed ID: 26549119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Squamous cell carcinoma of the temporal bone.
    Moffat DA; Wagstaff SA
    Curr Opin Otolaryngol Head Neck Surg; 2003 Apr; 11(2):107-11. PubMed ID: 14515088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Squamous cell carcinoma of the temporal bone: diagnosis, treatment and prognosis.
    Chee G; Mok P; Sim R
    Singapore Med J; 2000 Sep; 41(9):441-6, 451. PubMed ID: 11193117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and pathological parameters prognostic for increased risk of recurrence after postoperative radiotherapy for temporal bone carcinoma.
    Marioni G; Zanoletti E; Giacomelli L; Braggio L; Martini A; Mazzoni A
    Head Neck; 2016 Jun; 38(6):894-8. PubMed ID: 26348213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival outcomes in surgical treatment of 72 cases of squamous cell carcinoma of the temporal bone.
    Chi FL; Gu FM; Dai CF; Chen B; Li HW
    Otol Neurotol; 2011 Jun; 32(4):665-9. PubMed ID: 21436754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Squamous cell carcinoma of the temporal bone.
    Bibas AG; Ward V; Gleeson MJ
    J Laryngol Otol; 2008 Nov; 122(11):1156-61. PubMed ID: 18177533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhabdomyosarcoma and other pediatric temporal bone malignancies.
    Gluth MB
    Otolaryngol Clin North Am; 2015 Apr; 48(2):375-90. PubMed ID: 25650231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal bone rhabdomyosarcoma in children.
    Sbeity S; Abella A; Arcand P; Quintal MC; Saliba I
    Int J Pediatr Otorhinolaryngol; 2007 May; 71(5):807-14. PubMed ID: 17346806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the prognostic role of pSTAT3 expression in temporal bone squamous cell carcinoma.
    Marioni G; Nucci R; Marino F; Cappellesso R; Pillon M; Zanoletti E; Giacomelli L; Franchella S; Billo P; Pareschi R; Martini A
    Otol Neurotol; 2013 Oct; 34(8):1476-82. PubMed ID: 24005169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of 95 cases of squamous cell carcinoma of the external and middle ear.
    Yin M; Ishikawa K; Honda K; Arakawa T; Harabuchi Y; Nagabashi T; Fukuda S; Taira A; Himi T; Nakamura N; Tanaka K; Ichinohe M; Shinkawa H; Nakada Y; Sato H; Shiga K; Kobayashi T; Watanabe T; Aoyagi M; Ogawa H; Omori K
    Auris Nasus Larynx; 2006 Sep; 33(3):251-7. PubMed ID: 16431060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal bone carcinoma: Treatment patterns and survival.
    Seligman KL; Sun DQ; Ten Eyck PP; Schularick NM; Hansen MR
    Laryngoscope; 2020 Jan; 130(1):E11-E20. PubMed ID: 30874314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasion patterns of advanced temporal bone malignancies.
    Leonetti JP; Smith PG; Kletzker GR; Izquierdo R
    Am J Otol; 1996 May; 17(3):438-42. PubMed ID: 8817022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
    Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
    Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elective parotidectomy in the management of advanced auricular malignancies.
    Osborne RF; Shaw T; Zandifar H; Kraus D
    Laryngoscope; 2008 Dec; 118(12):2139-45. PubMed ID: 19029866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carcinoma of the temporal bone--current diagnostic and therapeutic aspects].
    Issing PR; Kempf HG; Schönermark M; Lenarz T
    Laryngorhinootologie; 1995 Nov; 74(11):666-72. PubMed ID: 8561818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.